Coreline Soft AI powers French national lung cancer pilot and more briefs
Coreline Soft AI powers French national lung cancer pilot and more briefs | MobiHealthNews
Skip to main content…
Continue ReadingCoreline Soft AI powers French national lung cancer pilot and more briefs | MobiHealthNews
Skip to main content…
Continue ReadingFaced with the complexity of more than 50 interconnected IT systems, the innovative Schützen Rheinfelden Clinic turned this challenge into an opportunity. Under the leadership of IT director Matthias Meyer, the clinic chose Enovacom…
Continue ReadingThe vision for Optum Real is to create real-time transparency between payers and providers in the moments of care that matter. Current AI technology, according to Puneet Maheshwari, SVP, GM of Optum Real is…
Continue ReadingBackground: Smoking cessation remains a global challenge, with traditional treatments showing limited long-term success due to low adherence and accessibility issues. Digital therapeutics, such as mobile apps and virtual reality (VR)–based interventions, could offer…
Continue ReadingMedForceAI creates specialist diagnostic generative artificial intelligence (GenAI) products, which are designed to reduce waiting lists and prevent adverse events. Jay Liu, Co-founder and CEO at MedForceAI, enrolled on the RADIANT-CERSI Innovator Support programme with the ambition of strengthening his regulatory knowledge for AI as a medical device (AIaMD), as well as developing a clear regulatory roadmap, including timelines…
Continue Readingemtelligent offers a variety of AI-based services in health care. In a recent interview at the HLTH conference with Tim O’Connell, MD, Co-Founder and CEO of emtelligent, explains how they ensure a good ROI,…
Continue ReadingThe Department of Health and Social Care has announced 45 pilot schemes across England using remote monitoring and self-reporting tools through the NHS App.
Once in full flow, remote monitoring is expected to free up…
Overview of the 340B Rebate Pilot Program
The Trump administration has officially approved eight drugmakers’ rebate plans for a controversial 340B drug discount pilot program launching January 1, 2025. This groundbreaking initiative, unveiled earlier this…
Dr Oliver Hulson, consultant radiologist at Leeds Teaching Hospitals NHS Trust (LTHT) who is leading the trial in Leeds (Credit: LTHT)
An AI-powered service for prostate cancer which can spot lesions in minutes will…
Continue ReadingBackground: Chinese Americans with type 2 diabetes (T2D) face many linguistic, cultural, and social determinants of health–related barriers to accessing evidence-based diabetes interventions. Our team developed the culturally and linguistically tailored Chinese American Research…
Continue Reading